• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

H274Y's Effect on Oseltamivir Resistance: What Happens Before the Drug Enters the Binding Site

tetano

Editor, Senior Moderator
J Chem Inf Model. 2015 Dec 24. [Epub ahead of print]
[h=1]H274Y's Effect on Oseltamivir Resistance: What Happens Before the Drug Enters the Binding Site.[/h] Yusuf M, Mohamed N, Mohamad S, Janezic D, Damodaran KV, Wahab H.
[h=3]Abstract[/h] Increased reports of oseltamivir (OTV) resistant strains of the influenza virus, such as H274Y mutation on its neuraminidase (NA), have created some cause for concern. Many studies were conducted in the attempt to uncover the mechanism of OTV resistance in H274Y NA. However, most of the reported studies on H274Y only focused on the drug-bound system, but direct effects of the mutation toward NA itself prior to drug binding still remain unclear. Therefore, molecular dynamics simulations of NA in apo form, followed by principal component analysis and interaction energy calculation, were performed to investigate the structural changes of the NA binding site as a result of H274Y mutation. It was observed that the disruption of the NA binding site due to H274Y was initiated by the repulsive effect of Y274 on the 250-loop, which in turn altered the hydrogen bond network around residue 274. The rotated W295 side chain caused the upward movement of the 340-loop. Consequently, sliding box docking results suggested that the binding pathway of OTV was compromised due to the disruption of this binding site. This study also highlighted the importance of the functional group at position C6 of sialic acid mimicry. It is hoped that these results could improve the understanding of OTV resistances and shed some light on the design of a novel anti-influenza drug.


PMID: 26703840 [PubMed - as supplied by publisher]
 
Back
Top Bottom